Susquehanna International Group’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Susquehanna International Group’s Portfolio PLXP Stock Details PLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-52,728	Closed	-$6.86K	–	13743
2023 Q1	$6.86K	Sell	52,728 -508	-1%	-$103	﹤0.01%	12263
2022 Q4	$8.74K	Buy	53,236 +7,572	+17%	+$3.17K	﹤0.01%	11956
2022 Q3	$30K	Buy	45,664 +8,414	+23%	+$12.4K	﹤0.01%	12452
2022 Q2	$91K	Sell	37,250 -63,800	-63%	-$177K	﹤0.01%	11558
2022 Q1	$408K	Sell	101,050 -27,665	-21%	-$152K	﹤0.01%	9496
2021 Q4	$1.03M	Sell	128,715 -42,495	-25%	-$498K	﹤0.01%	7218
2021 Q3	$3.3M	Buy	171,210 +113,618	+197%	+$1.99M	﹤0.01%	4762
2021 Q2	$795K	Buy	+57,592	New	+$682K	﹤0.01%	8397
2018 Q1	–	Sell	-77,706	Closed	-$536K	–	10432
2017 Q4	$536K	Sell	77,706 -74,194	-49%	-$515K	﹤0.01%	6507
2017 Q3	$987K	Sell	151,900 -77,900	-34%	-$500K	﹤0.01%	5288
2017 Q2	$1.41M	Buy	+229,800	New	+$1.68M	﹤0.01%	4548

Other funds holding PLXP

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.28B AUM 38.1% 1-Year Est. Return

Susquehanna International Group's PLXP Position: Q2 2023 in Review

Susquehanna International Group sold out of PLx Pharma Inc. Common Stock (PLXP) in Q2 2023, closing a stake of 52,728 shares — an estimated $6.86K sold.

Susquehanna International Group first reported a position in PLXP in Q2 2017 and held it in 11 quarters. The position peaked at $3.3M in Q3 2021. 4 funds tracked by Wall St. Rank hold PLXP as of Q2 2023.

Susquehanna International Group reported no remaining PLx Pharma Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Susquehanna International Group sold 52,728 PLx Pharma Inc. Common Stock shares in Q2 2023, an estimated $6.86K.
Susquehanna International Group first reported a position in PLx Pharma Inc. Common Stock in Q2 2017 and held it in 11 quarters.
Susquehanna International Group's PLx Pharma Inc. Common Stock position peaked at $3.3M in Q3 2021.
4 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.